CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS ([*]), HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24B-2 OF THE EXCHANGE ACT OF 1934, AS AMENDED RESEARCH...And License Agreement • May 11th, 2009 • Combinatorx, Inc • Pharmaceutical preparations • Massachusetts
Contract Type FiledMay 11th, 2009 Company Industry JurisdictionThis Research Collaboration and License Agreement (this “Agreement”) is dated as of May 1, 2009 (the “Effective Date”), by and between CombinatoRx, Incorporated, a Delaware corporation with principal offices at 245 First Street, Fourth Floor, Cambridge, MA 02142 (“CombinatoRx”), and Novartis Institutes for BioMedical Research, Inc., a Delaware corporation with principal offices at 250 Massachusetts Avenue, Cambridge, MA 02139 (“Novartis”).
SOFTWARE LICENSE AGREEMENTSoftware License Agreement • May 11th, 2009 • Combinatorx, Inc • Pharmaceutical preparations • Massachusetts
Contract Type FiledMay 11th, 2009 Company Industry JurisdictionSoftware License Agreement (this “Agreement”) dated as of May 1, 2009, (the “Effective Date”) by and between CombinatoRx, Incorporated, 245 1st Street, Fourth Floor, Cambridge, Massachusetts 02142 (“CombinatoRx”) and Novartis Institutes for BioMedical Research, Inc., 250 Massachusetts Avenue, Cambridge, Massachusetts 02139 (“Novartis”).